The Interface between Cell Signaling Pathways and Pregnane X Receptor
Authors:
- Robert S. RogersRRRobert S. Rogers
- Annemarie ParkerAPAnnemarie Parker
- Phill D. VainerPVPhill D. Vainer
- Elijah ElliottEEElijah Elliott
- Dakota SudbeckDSDakota Sudbeck
- Kaushal ParimiKPKaushal Parimi
- Venkata P. PeddadaVPVenkata P. Peddada
- Parker G. HowePHParker G. Howe
- Nick D’ambrosioNDNick D’ambrosio
- Gregory RuddyGRGregory Ruddy
- Kaitlin StackableKSKaitlin Stackable
- Megan CarneyMCMegan Carney
Open Access
Abstract
Highly expressed in the enterohepatic system, pregnane X receptor (PXR, NR1I2) is a well-characterized nuclear receptor (NR) that regulates the expression of genes in the liver and intestines that encode key drug metabolizing enzymes and drug transporter proteins in mammals. The net effect of PXR activation is to increase metabolism and clear drugs and xenobiotics from the body, producing a protective effect and mediating clinically significant drug interaction in patients on combination therapy. The complete understanding of PXR biology is thus important for the development of safe and effective therapeutic strategies. Furthermore, PXR activation is now known to specifically transrepress the inflammatory- and nutrient-signaling pathways of gene expression, thereby providing a mechanism for linking these signaling pathways together with enzymatic drug biotransformation pathways in the liver and intestines. Recent research efforts highlight numerous post-translational modifications (PTMs) which significantly influence the biological function of PXR. However, this thrust of research is still in its infancy. In the context of gene-environment interactions, we present a review of the recent literature that implicates PXR PTMs in regulating its clinically relevant biology. We also provide a discussion of how these PTMs likely interface with each other to respond to extracellular cues to appropriately modify PXR activity.Keywords
This publication has 127 references indexed in Scilit:
- Emerging roles of the corepressors NCoR1 and SMRT in homeostasisGenes & Development, 2013
- Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic responseCancer Letters, 2013
- Molecular Insights into Poly(ADP-ribose) Recognition and ProcessingBiomolecules, 2012
- Post-translational modification of pregnane x receptorPharmacological Research, 2011
- Acetylation of pregnane X receptor protein determines selective function independent of ligand activationBiochemical and Biophysical Research Communications, 2011
- A Systematic Analysis of Predicted Phosphorylation Sites within the Human Pregnane X Receptor ProteinThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Cyclic AMP-dependent Protein Kinase Signaling Modulates Pregnane x Receptor Activity in a Species-specific MannerJournal of Biological Chemistry, 2009
- Involvement of linear polyubiquitylation of NEMO in NF-κB activationNature Cell Biology, 2009
- The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor proteinOncogene, 2000